Search clinical trials for: Aczone

Total 22 results

Icahn School of Medicine at Mount Sinai

Completed

Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color

Acne Vulgaris

United States
Torrent Pharmaceuticals Limited
Catawba Research

Completed

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize
Almirall, S.A.
Allergan

Completed

Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Acne Vulgaris

United States
Allergan

Completed

Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris

Acne Vulgaris

United States
Derm Research, PLLC

Completed

Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris

Acne

United States
Vanderbilt University Medical Center

Terminated

Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis

Dermatitis Herpetiformis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Allergan

Completed

A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris

Acne Vulgaris

United States
Derm Research, PLLC
WFH MEDICAL, LLC

Completed

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

Acne Vulgaris

United States
Nathan Wei, MD, FACP, FACR:
Medtronic - MITG; Arthritis Treatment Center, Maryland

Completed

Trial to See if Topical Pennsaid for Knee Pain Affects Coagulation Values in Patients Who Are Also Taking Anticoagulants (ATCCTCP-1)

Osteoarthritis of the Knee | Coagulopathy

United States
John H. Stroger Hospital

Unknown

Dapsone Prurigo Study

Lichen Simples Chronicus and Prurigo

United States
Allergan

Withdrawn

An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris

Acne Vulgaris
Allergan

Withdrawn

Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne

Acne Vulgaris
Allergan

Completed

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

Acne Vulgaris

United States
Bausch Health Americas, Inc.

Completed

A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products

Acne Vulgaris

United States
Allergan

Completed

Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris

Acne Vulgaris

United States
Allergan

Completed

Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris

Acne Vulgaris

United States
Allergan

Terminated

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Rash | Non-small-Cell Lung Cancer

United States
Allergan

Completed

Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency

Acne Vulgaris

United States
Allergan

Completed

A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.

Rosacea

United States

3

Subscribe